myasthenia gravis造句

"myasthenia gravis"是什么意思   

例句与造句

  1. A clinical assessment of ocular myasthenia gravis
    眼肌型重症肌无力临床分析
  2. Clinical study on the ocular myasthenia gravis
    眼肌型重症肌无力的临床研究
  3. Study of repeated nerve stimulation in myasthenia gravis
    重症肌无力重复神经刺激的研究
  4. Acupuncture and medicine treating ocular myasthenia gravis
    针药并用治疗眼型重症肌无力
  5. Dr . qiu changling ' s experience on treating myasthenia gravis
    裘昌林治疗重症肌无力的经验
  6. It's difficult to find myasthenia gravis in a sentence. 用myasthenia gravis造句挺难的
  7. Therapeutic progress about myasthenia gravis of ocular type
    眼肌型重症肌无力的治疗进展
  8. Paying attention to early standardized diagnosis of myasthenia gravis
    重视重症肌无力的早期规范化诊断
  9. Report on one case of myasthenia gravis with buzhongyiqi decoction
    捻针法穿刺引流治疗单纯甲下血肿55例
  10. Child myasthenia gravis eye muscle type treated by integrated tcm and wm
    中西医结合治疗儿童眼肌型重症肌无力87例
  11. Blood plasma replacement and small dose hormone in treating myasthenia gravis
    血浆置换联合小剂量激素治疗重症肌无力的疗效观察
  12. Dysfunction of central nervous system in passive immunized myasthenia gravis models
    被动免疫重症肌无力模型中枢神经系统损害的探讨
  13. Combined therapy of high - dose intravenous immunoglobulin and methylprednisolone in treating myasthenia gravis
    甲基强的松龙治疗重症肌无力
  14. A study of magnetic motor evoked potentials in the central nervous system dysfunction model of myasthenia gravis
    大鼠重症肌无力中枢损害运动诱发电位研究
  15. Observation on therapeutic effect of warming needle moxibustion combined with medicine on 128 cases of myasthenia gravis
    温针灸为主治疗慢性前列腺炎疗效观察
  16. Background : myasthenia gravis is an autoimmune disease in which autoantibodies interfere with neuromuscular transmission
    背景:重症肌无力是一种由于自身抗体妨碍神经肌肉接头传导的自身免疫疾病。
  17. 更多例句:  下一页

相关词汇

  1. "myasnikyan"造句
  2. "myasnitsky"造句
  3. "myasoyedov"造句
  4. "myastenia gravis"造句
  5. "myasthenia"造句
  6. "myasthenia gravis foundation"造句
  7. "myasthenia gravis pseudoparalytica"造句
  8. "myastheniagravis"造句
  9. "myasthenias"造句
  10. "myasthenic"造句
电脑版繁體版English日本語한국어

Copyright © 2023 WordTech Co.